Ara Dikranian

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Cem Gabay, Paul Emery, Ronald van Vollenhoven et al. · The Lancet · 2013 · 664 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +8

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve‐week, randomized, placebo‐controlled trial

Michael E. Weinblatt, Arthur Kavanaugh, Rubén Burgos‐Vargas et al. · Arthritis & Rheumatism · 2008 · 334 citations

Model‐Informed Development and Registration of a Once‐Daily Regimen of Extended‐Release Tofacitinib

M. Lamba, MM Hutmacher, D.E. Furst et al. · Clinical Pharmacology & Therapeutics · 2016 · 38 citations · Full text

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies

Ara Dikranian, Miguel Á. González‐Gay, Frank R. Wellborne et al. · RMD Open · 2022 · 29 citations · Full text